Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 18

3.

Spotlight on abciximab in patients with ischemic heart disease undergoing percutaneous coronary revascularization.

Ibbotson T, McGavin JK, Goa KL.

Am J Cardiovasc Drugs. 2003;3(5):381-6. Review.

PMID:
14728074
5.

An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors.

Adgey AA.

Eur Heart J. 1998 Apr;19 Suppl D:D10-21. Review.

PMID:
9597518
6.

Optimizing antiplatelet therapy in coronary interventions.

King SB 3rd.

Clin Cardiol. 2000 Nov;23 Suppl 6:VI-8-13. Review.

7.

Glycoprotein IIb-IIIa inhibitors for acute ischaemic stroke.

Ciccone A, Motto C, Abraha I, Cozzolino F, Santilli I.

Cochrane Database Syst Rev. 2014 Mar 8;(3):CD005208. doi: 10.1002/14651858.CD005208.pub3. Review.

PMID:
24609741
8.

A risk-benefit assessment of abciximab in angioplasty.

Kleiman NS.

Drug Saf. 1999 Jan;20(1):43-57. Review.

PMID:
9935276
9.

Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease.

Lincoff AM, Califf RM, Topol EJ.

J Am Coll Cardiol. 2000 Apr;35(5):1103-15. Review.

10.

Safety of glycoprotein IIb-IIIa inhibitors: A heart surgeon's perspective.

Dyke CM.

Am Heart J. 1999 Oct;138(4 Pt 2):307-16. Review.

PMID:
10502236
11.
12.
13.

Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes.

Bosch X, Marrugat J, Sanchis J.

Cochrane Database Syst Rev. 2013 Nov 8;(11):CD002130. doi: 10.1002/14651858.CD002130.pub4. Review.

PMID:
24203004
14.

Platelet glycoprotein IIb/IIIa blockers during percutaneous coronary intervention and as the initial medical treatment of non-ST segment elevation acute coronary syndromes.

Bosch X, Marrugat J, Sanchis J.

Cochrane Database Syst Rev. 2013 Oct 18;(10):CD002130. doi: 10.1002/14651858.CD002130.pub3. Review. Update in: Cochrane Database Syst Rev. 2013;(11):CD002130.

PMID:
24136036
15.

Use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.

Parmar R, Stouffer GA.

Am J Med Sci. 1997 Jul;314(1):31-6. Review. No abstract available.

PMID:
9216438
16.

Antithrombotic therapy in patients undergoing coronary angioplasty.

Popma JJ, Weitz J, Bittl JA, Ohman EM, Kuntz RE, Lansky AJ, King SB 3rd.

Chest. 1998 Nov;114(5 Suppl):728S-741S. Review. No abstract available.

PMID:
9822074
17.
18.

Platelet GPIIb-IIIa blockers.

Topol EJ, Byzova TV, Plow EF.

Lancet. 1999 Jan 16;353(9148):227-31. Review.

PMID:
9923894
Items per page

Supplemental Content

Write to the Help Desk